Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis

Objective To investigate the application of 16S rRNA in diagnosing patients with neonatal sepsis. Methods We studied 60 consecutive neonatal patients with clinically suspected sepsis and 20 non-infective cases as controls. All patients were diagnosed with sepsis by clinical and experimental criteria...

Full description

Bibliographic Details
Main Authors: Renqiang Yu, Qin Zhou, Shanyu Jiang, Yingzi Mei, Min Wang
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Journal of International Medical Research
Online Access:https://doi.org/10.1177/0300060519892418
_version_ 1819140989605904384
author Renqiang Yu
Qin Zhou
Shanyu Jiang
Yingzi Mei
Min Wang
author_facet Renqiang Yu
Qin Zhou
Shanyu Jiang
Yingzi Mei
Min Wang
author_sort Renqiang Yu
collection DOAJ
description Objective To investigate the application of 16S rRNA in diagnosing patients with neonatal sepsis. Methods We studied 60 consecutive neonatal patients with clinically suspected sepsis and 20 non-infective cases as controls. All patients were diagnosed with sepsis by clinical and experimental criteria. Clinical characteristics were recorded and 16S rRNA sequencing was conducted for all patients. The sensitivity, specificity, and accuracy of the detection methods were analyzed. Results The detection limit of 16S rRNA sequencing was 1 × 10 2 CFU/mL. For suspected sepsis, the positive rate of 16S rRNA detection was 93.3%, which was similar to that of procalcitonin detection (85%), and was significantly higher than that of bacterial culture (51.7%). The specificity of procalcitonin detection (74.1%) was significantly lower than that of 16S rRNA detection (100%). Moreover, the combination of 16S rRNA and procalcitonin detection showed a sensitivity of 100%, specificity of 74.1%, and accuracy of 92.0%. For proven sepsis, the sensitivity and specificity of 16S rRNA detection were both 100.0%, and those for procalcitonin were 87.1% and 87.0%, respectively. Conclusion Detection of 16S rRNA has high sensitivity and specificity in diagnosing sepsis. The combination of 16S rRNA and procalcitonin has even better sensitivity with acceptable specificity.
first_indexed 2024-12-22T11:47:19Z
format Article
id doaj.art-4f7e784272bb41a6b63c0edf54a01948
institution Directory Open Access Journal
issn 1473-2300
language English
last_indexed 2024-12-22T11:47:19Z
publishDate 2020-10-01
publisher SAGE Publishing
record_format Article
series Journal of International Medical Research
spelling doaj.art-4f7e784272bb41a6b63c0edf54a019482022-12-21T18:27:07ZengSAGE PublishingJournal of International Medical Research1473-23002020-10-014810.1177/0300060519892418Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsisRenqiang YuQin ZhouShanyu JiangYingzi MeiMin WangObjective To investigate the application of 16S rRNA in diagnosing patients with neonatal sepsis. Methods We studied 60 consecutive neonatal patients with clinically suspected sepsis and 20 non-infective cases as controls. All patients were diagnosed with sepsis by clinical and experimental criteria. Clinical characteristics were recorded and 16S rRNA sequencing was conducted for all patients. The sensitivity, specificity, and accuracy of the detection methods were analyzed. Results The detection limit of 16S rRNA sequencing was 1 × 10 2 CFU/mL. For suspected sepsis, the positive rate of 16S rRNA detection was 93.3%, which was similar to that of procalcitonin detection (85%), and was significantly higher than that of bacterial culture (51.7%). The specificity of procalcitonin detection (74.1%) was significantly lower than that of 16S rRNA detection (100%). Moreover, the combination of 16S rRNA and procalcitonin detection showed a sensitivity of 100%, specificity of 74.1%, and accuracy of 92.0%. For proven sepsis, the sensitivity and specificity of 16S rRNA detection were both 100.0%, and those for procalcitonin were 87.1% and 87.0%, respectively. Conclusion Detection of 16S rRNA has high sensitivity and specificity in diagnosing sepsis. The combination of 16S rRNA and procalcitonin has even better sensitivity with acceptable specificity.https://doi.org/10.1177/0300060519892418
spellingShingle Renqiang Yu
Qin Zhou
Shanyu Jiang
Yingzi Mei
Min Wang
Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
Journal of International Medical Research
title Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
title_full Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
title_fullStr Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
title_full_unstemmed Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
title_short Combination of 16S rRNA and procalcitonin in diagnosis of neonatal clinically suspected sepsis
title_sort combination of 16s rrna and procalcitonin in diagnosis of neonatal clinically suspected sepsis
url https://doi.org/10.1177/0300060519892418
work_keys_str_mv AT renqiangyu combinationof16srrnaandprocalcitoninindiagnosisofneonatalclinicallysuspectedsepsis
AT qinzhou combinationof16srrnaandprocalcitoninindiagnosisofneonatalclinicallysuspectedsepsis
AT shanyujiang combinationof16srrnaandprocalcitoninindiagnosisofneonatalclinicallysuspectedsepsis
AT yingzimei combinationof16srrnaandprocalcitoninindiagnosisofneonatalclinicallysuspectedsepsis
AT minwang combinationof16srrnaandprocalcitoninindiagnosisofneonatalclinicallysuspectedsepsis